MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, EVFM made $899K in revenue. -$5,485K in net income. Net profit margin of -610.12%.

Income Overview

Revenue
$899K
Net Income
-$5,485K
Net Profit Margin
-610.12%
EPS
-$0.04
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Product sales, net
899 9,561 4,952 4,825
Cost of goods sold
410 2,592 905 755
Amortization of intangible asset
---107
Loss on change in accounting estimates on contingent royalty liability (note 7)
--3,866* 1,933 -
Amortization of intangible asset
75 96 80 100
Research and development, net
518 -3,501* 470 746
Selling and marketing
2,093 2,066 2,391 2,625
General and administrative
2,372 1,097 2,088 1,843
Total operating expenses
5,468 6,216 4,001 6,076
Income (loss) from operations
-4,569 3,345 951 -1,251
Interest income
2 2 3 2
Gain on debt extinguishment, net
---0
Loss on issuance of financial instruments
---0
Other expense, net
737 691 682 662
Change in fair value of financial instruments
-162 131 -1,845 134
Total other income (expense), net
-897 -558 -2,524 -526
Income (loss) before income tax expense
-5,466 2,787 -1,573 -1,777
Income tax expense
-1 -1 -4 7
Net income (loss)
-5,465 2,788 -1,569 -1,784
Convertible and redeemable preferred stock deemed dividends
20 2 111 -1
Net income (loss) attributable to common stockholders
-5,485 2,786 -1,680 -1,785
Basic EPS
-0.04 0.019 -0.01 -0.02
Diluted EPS
-0.04 0 -0.01 -0.02
Basic Average Shares
133,246,864 146,011,189 119,578,093 115,686,024
Diluted Average Shares
133,246,864 6,421,746,555* 119,578,093 115,686,024
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net income (loss)attributable to common...-$5,485K (-675.55%↓ Y/Y)Net income (loss)-$5,465K (-671.65%↓ Y/Y)Convertible and redeemablepreferred stock deemed...$20K (766.67%↑ Y/Y)Income tax expense-$1K Income (loss) beforeincome tax expense-$5,466K (-671.76%↓ Y/Y)Income (loss) fromoperations-$4,569K (-1497.25%↓ Y/Y)Total other income(expense), net-$897K (-242.61%↓ Y/Y)Product sales, net$899K (6.39%↑ Y/Y)Interest income$2K (-75.00%↓ Y/Y)Total operatingexpenses$5,468K (955.60%↑ Y/Y)Other expense, net$737K (22.83%↑ Y/Y)Change in fair value offinancial instruments-$162K (-113.27%↓ Y/Y)General andadministrative$2,372K (0.30%↑ Y/Y)Selling and marketing$2,093K (-19.50%↓ Y/Y)Research anddevelopment, net$518K (110.29%↑ Y/Y)Cost of goods sold$410K (12.33%↑ Y/Y)Amortization of intangibleasset$75K (-66.37%↓ Y/Y)

Evofem Biosciences, Inc. (EVFM)

Evofem Biosciences, Inc. (EVFM)